Uveal Melanoma UK National GuidelinesPrimary intraocular lymphoma of T-cell type: report of a case and review of the literatureMultiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic deathTargeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanomaGDF-15: a novel serum marker for metastases in uveal melanoma patients.Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testingOcular adnexal lymphomas: five case presentations and a review of the literature.Immunohistochemical analysis indicates that the anatomical location of B-cell non-Hodgkin's lymphoma is determined by differentially expressed chemokine receptors, sphingosine-1-phosphate receptors and integrinsPlasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 casesPrimary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.Differences in uveal melanomas between men and women from the British IslesEvaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus.Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.Conjunctival melanoma and melanocytic intra-epithelial neoplasia.Molecular pathology of uveal melanomaUnderstanding intraocular lymphomas.In-depth proteomic profiling of the uveal melanoma secretome.Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors.The challenge of the microenvironment in B-cell lymphomas.Estimating prognosis for survival after treatment of choroidal melanoma.Analysis of intraocular biopsies.Cancer of the orbit and adnexa.Molecular pathology of lymphomaIntraocular collision tumour: case report and literature review.Motility and trafficking in B-cell non-Hodgkin's lymphoma (Review).Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas.BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions.Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer.Malignant lymphoma of the conjunctiva.High Frequency of Malignant Transformation of Ovarian Mature Teratoma into Squamous Cell Carcinoma in Young Patients in Northeast Brazil.A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.The epidemiology, clinical characteristics, histopathology and management of juvenile- and adult-onset corneoscleral limbus xanthogranuloma.MicroRNA Expression Profile in Conjunctival Melanoma.External Validation of the Liverpool Uveal Melanoma Prognosticator Online.Lymphoid hyperplasia of the orbit and ocular adnexa: A clinical pathologic review.How we diagnose and treat vitreoretinal lymphoma.Lymphoma of the Eyelid - An International Multicenter Retrospective Study.Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.Benign reactive lymphoid hyperplasia of the conjunctiva in childhood.An audit of conjunctival melanoma treatment in Liverpool.
P50
Q26798061-A39C241C-99BB-4780-8693-B0774473ECF9Q28243211-2A8D4424-67D6-4B9B-AEF8-C88292F338E3Q28307945-A5A23307-E229-49CD-A209-FEE8C728258EQ33994399-C9069C9B-134F-4116-AC10-A1557A54F8F3Q34007029-735E066A-723D-4111-AB32-D25950493511Q34283714-7C0EF3B7-399E-4E95-A51A-CBEBA9614456Q34996914-FF409EFD-5079-4D04-A3BA-18ABC4CA4530Q35559414-4DC9A9C1-92A9-4194-A37F-DE0BFD13A4AFQ35592944-E34BEBA7-B66B-4428-90D1-D7B7CC04E063Q35599811-607B848B-2184-4009-99B1-399BB03A088DQ35737358-BA476AED-F384-4183-A6A2-19C8C57DF627Q35834551-8F5B79D9-7AE7-40E8-BB63-288A6F4638CBQ35914160-8056B254-5A38-4746-B13C-17719BF2EDEFQ36615052-61CE2C7A-F8BA-4483-A191-A883991E9003Q36615059-802C1C1C-E679-4058-BA47-06F909C2A356Q37309437-DB1C7135-8569-457D-B928-A0ACEF9ACDA5Q37580290-91BDEF36-693F-4FD9-8BD9-A7E9796A1A85Q37660216-FB94207B-471C-48B5-B9F3-C8BDBF7CBD20Q37831956-934BBDCE-E747-4780-B72D-94025D276293Q37887118-5D54E8F3-0E8F-4B13-9D78-555143A492FAQ37951347-2DDBA055-B879-4D09-97C0-D763F93DCB81Q37966888-B7C91834-6802-462F-8C37-7A14480A8ACBQ38065892-4FF8119E-8E89-47C4-B070-A8BCFE7944D2Q38066727-2D673D5F-C616-4A3B-9FFD-66861578442BQ38208731-2311B78C-0625-471E-B0D8-90437981AD60Q38380879-6C7DD2CD-6EF8-4194-AEDA-76EC8696814CQ38381486-9892691E-ABA7-4FE6-9A1A-AC9865687DB8Q38426642-9C26109B-4C97-47F3-A6DA-326458674B6AQ38499978-711F8F3D-94DF-4A58-A751-9951E5057E03Q38586477-56854307-3C4F-4B35-ADFF-0CA891E9780EQ38596535-1E71B046-CD57-4101-A687-35EAFB046970Q38705653-12C799C2-25CF-4D63-9359-007D45D0834EQ38750728-28607BD2-FF32-4D06-836D-E052DD13DFE7Q38796421-455FFCAB-DF0C-469D-B087-47C2B57A5842Q38820623-3AC25D2C-69B1-4FD6-A699-01123DDC064CQ38822438-AC12A924-D4EB-4CE6-8C76-603E4F93B33DQ38956559-DB0FC862-7ED4-43FB-8F21-6985A614B426Q38984356-766B857A-80F5-489D-BD4C-B8C0EEF72300Q39023863-EE3A7ACA-345F-4A1D-96EA-A99C791385FAQ39211032-23B040E0-2098-4113-8C6C-6F0DFA02FC59
P50
description
Australian clinical pathologist
@en
professor uit Australië
@nl
հետազոտող
@hy
name
Sarah Coupland
@en
Sarah Coupland
@nl
Sarah Coupland
@sq
Sarah E. Coupland
@ast
Sarah E. Coupland
@es
Sarah E. Coupland
@sl
type
label
Sarah Coupland
@en
Sarah Coupland
@nl
Sarah Coupland
@sq
Sarah E. Coupland
@ast
Sarah E. Coupland
@es
Sarah E. Coupland
@sl
altLabel
Sarah E. Coupland
@en
prefLabel
Sarah Coupland
@en
Sarah Coupland
@nl
Sarah Coupland
@sq
Sarah E. Coupland
@ast
Sarah E. Coupland
@es
Sarah E. Coupland
@sl
P1153
7004778304
P19
P21
P214
158147662880460550748
P27
P31
P496
0000-0002-1464-2069
P734
P735
P7859
viaf-158147662880460550748